Updated Jul 16, 2026
Newton Charles W. has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $24K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 550 | $10.04 | $6K |
| 2026-06-09 | CHRS | Coherus BioSciences, Inc. | A — Grant or award | 30.0K | $0.00 | |
| 2026-04-28 | NVAX | NOVAVAX INC | M — Option exercise | 9.5K | $0.00 | |
| 2026-03-11 | KROS | Keros Therapeutics, Inc. | A — Grant or award | 13.2K | $0.00 | |
| 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 1.5K | $10.54 | $15K |
| 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | A — Grant or award | 8.0K | $0.00 | |
| 2025-08-11 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 136 | $10.34 | $1K |
| 2025-08-11 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 131 | $10.53 | $1K |
Newton Charles W. is a corporate insider — currently tracked as Director of NOVAVAX INC (NVAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($24K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Newton Charles W. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.